Entering the 4th decade of Botox (onabotulinumtoxinA): A narrative review of its development and impact on patients and medicine

Medicine (Baltimore). 2023 Jul 1;102(S1):e32370. doi: 10.1097/MD.0000000000032370.
No abstract available

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Botulinum Toxins, Type A* / therapeutic use
  • Humans
  • Medicine*
  • Migraine Disorders*
  • Treatment Outcome

Substances

  • Botulinum Toxins, Type A